Hematology & CAR-T
CAR-T Therapy in China
Access to NMPA-approved CAR-T cell therapies or registered clinical trials for selected blood cancers, with eligibility decided by the hospital.
- Stay
- Often 6–10 weeks near the hospital in total; the hospital confirms the schedule
- Cost
- RMB 0.999–1.29 million list price for the CAR-T product, per infusion (about US$140,000–181,000) (indicative, confirmed by the hospital's quote)
Last reviewed October 20, 2026